Skip Nav Destination
Article navigation
Critical Care Medicine|
September 1990
A379 INHIBITION OF HUMAN LIVER ALFENTANIL METABOLISM BY MEDETOMIDINE STEREOISOMERS
H. F. Hill, PhD;
H. F. Hill, PhD
Depts. of Anesthesiology, Medicinal Chemistry and Surgery*, Univ. of Washington, and Division of Clinical Research, Fred Hutchinson Cancer Research Center†, Seattle, WA
Search for other works by this author on:
A. C. Eddy, MD
A. C. Eddy, MD
Depts. of Anesthesiology, Medicinal Chemistry and Surgery*, Univ. of Washington, and Division of Clinical Research, Fred Hutchinson Cancer Research Center†, Seattle, WA
Search for other works by this author on:
Anesthesiology September 1990, Vol. 73, NA.
Citation
E. D. Kharasch, H. F. Hill, A. C. Eddy; A379 INHIBITION OF HUMAN LIVER ALFENTANIL METABOLISM BY MEDETOMIDINE STEREOISOMERS. Anesthesiology 1990; 73:NA doi: https://doi.org/10.1097/00000542-199009001-00376
Download citation file:
37
Views
Citing articles via
Most Viewed
Related Articles
From Bench to Bedside and Back Again: A Personal Journey with Dexmedetomidine
Anesthesiology (September 2016)
Pharmacogenetic Determinants of Human Liver Microsomal Alfentanil Metabolism and the Role of Cytochrome P450 3A5
Anesthesiology (March 2005)
Alpha-2 Adrenoceptor Agonists Decrease Cyclic Guanosine 3',5'-Monophosphate in the Mouse Brain
Anesthesiology (September 1996)
